Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios

Eur Respir J. 2015 Jan;45(1):25-9. doi: 10.1183/09031936.00145014.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Cohort Studies
  • Communicable Disease Control / methods
  • Drug Resistance, Bacterial
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Humans
  • Linezolid / therapeutic use*
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization

Substances

  • Antitubercular Agents
  • Linezolid